Academic Highlights March 15, 2007

New Developments in the Treatment of Schizophrenia.

John M. Kane, MD; Stefan Leucht, MD; Stephen R. Marder, MD; Delbert G. Robinson, MD; Steven Siegel, MD, PhD

J Clin Psychiatry 2007;68(3):463-478

Article Abstract

Click to enlarge page

Schizophrenia is a disease that ranks in the top 5 causes of disability for young adults in developed countries.1 In addition to the delusions, hallucinations, and disturbances in affect that are characteristics of schizophrenia, the illness is also associated with impairments in the high-level functions of planning, learning, and social activity. The impairments of schizophrenia impact every aspect of a patient’s life and thereby have a debilitating effect on the patient’s ability to function in society.